Reprogramming Synthetic Cells for Targeted Cancer Therapy

[Image: see text] Advances in synthetic biology enable the reprogramming of bacteria as smart agents to specifically target tumors and locally release anticancer drugs in a highly controlled manner. However, the bench-to-bedside translation of engineered bacteria is often impeded by genetic instabil...

Descripción completa

Detalles Bibliográficos
Autores principales: Lim, Boon, Yin, Yutong, Ye, Hua, Cui, Zhanfeng, Papachristodoulou, Antonis, Huang, Wei E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2022
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9084601/
https://www.ncbi.nlm.nih.gov/pubmed/35255684
http://dx.doi.org/10.1021/acssynbio.1c00631

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9084601/
https://www.ncbi.nlm.nih.gov/pubmed/35255684
http://dx.doi.org/10.1021/acssynbio.1c00631

Ejemplares similares